Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Ireland agrees deal on medicines

June 28, 2012 Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing

Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …
News

FDA clears Arena and Eisai’s obesity drug

June 28, 2012 Sales and Marketing Arena, Belviq, Eisai, FDA, Qnexa, Roche, obesity

Eisai and Arena’s Belviq has gained FDA approval, making it the first obesity drug to be approved in over ten …
News

Astellas submits new prostate cancer drug to EMA

June 28, 2012 Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …
News

Witty warns EU leaders over pricing

June 27, 2012 Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …
News

ABPI to no longer ‘shy away’ from big issues

June 27, 2012 Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead

The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …
News

NICE final yes for Zytiga and Tarceva

June 27, 2012 Sales and Marketing Janssen, NHS, NICE, NSCLC, Roche, Tarceva, Zytiga

In final guidance published today, NICE is recommending two new drugs for patients with prostate and lung cancer. Janssen’s Zytiga …
News

Amylin withheld safety data, says FDA

June 27, 2012 Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …
News

Eisai to enter Russia with epilepsy launch

June 27, 2012 Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy

Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …
News

Roche cuts 1,000 R&D jobs

June 27, 2012 Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
News

Roche’s Perjeta increases survival

June 27, 2012 Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …
News

London Trust on the brink of going bust

June 26, 2012 Sales and Marketing Lansley, NHS, South London Healthcare, reforms

For the first time in its history an NHS Trust is facing bankruptcy and could be dissolved by the government. …
News

Generic approval for Shire’s hyperactivity drug

June 26, 2012 Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …
News

FDA delays Eliquis approval

June 26, 2012 Sales and Marketing BMS, Eliquis, FDA, Pfizer, Xarelto

The FDA has asked Pfizer and Bristol-Myers Squibb for more information about its key blood thinner Eliquis. The US regulator …
News

FDA rejects licence extension for Xarelto

June 26, 2012 Sales and Marketing ACS, Bayer, FDA, J&J, JJ, Pradaxa, Xarelto

The FDA has set a Complete Response Letter to Bayer and J&J over its blood thinner Xarelto. The firms, which …
News

MPs find NHS bodies still blocking treatments

June 25, 2012 Sales and Marketing CCGs, MPs, NHS, NICE, PCTs, Pfizer, viagra

The Labour party has uncovered new restrictions to treatments and drugs in the NHS, which it says is hurting patients …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026